George Mason University Appoints Claire Dwoskin

Claire Dwoskin was appointed to the Board of Visitors at George Mason University in the beginning of June. The university is located in Fairfax, Virginia which holds a 16 member board that exercises its authority principally in policy-making and oversight.

Dwoskin, alongside three other new appointees, will serve a four-year term starting July 1, 2014 and ending June 30, 2018. The 16 members are appointed by the Governor of Virginia, Gov. Terry McAuliffe, and serve on a rotating basis. These members are the corporate and governing body of the university that work under the leadership of a rector, vice rector and secretary.

Some of the duties Dwoskin will be responsible for include setting tuition rates, approving the university’s budget and appointing the university president. Currently, George Mason University is home to approximately 21,000 undergraduate students and 12,000 graduate students.

The Board of Visitors was established at the university in April 1972 when the school became an independent institution and has since assisted with the operations of the university. Meetings of the Board of Visitors and its committees are open to the public, except in the case of executive sessions.

With Dwoskin’s background in funding scientific research into chronic health conditions among young children and the elderly, she may be able to provide guidance on the importance of academic research as both a stimulant to economic growth and as an important factor in understanding societal and economic trends. Her family foundation has funded highly accessed research through Children’s Medical Safety Research Institute. Specifically, CMSRI is funding research into the causal factors underlying the increases in the prevalence of previously rare disorders that are becoming more frequent, such as serious autoimmune health conditions and age related disorders in the nervous system.

CMSRI is focused on discovering changes in human exposures which may be a leading cause to chronic health conditions like immune, inflammatory and cognitive disorders in children and adults ranging from asthma to neurodevelopmental disorders. Understanding the root causes is the key to preventing these conditions, as well as in developing more effective treatments and cures. Knowledge obtained through academic research funded by her foundation will likely spark new medical and therapeutic advances as well as reduce costs associated with conditions that can be prevented.

A vast amount of research has been conducted regarding the use of vaccines and their effects on the body because it is believed that some ingredients spur adverse reactions. One ingredient used in many vaccines is aluminum – which, when used as an adjuvant, has the potential to be toxic and harmful to every organ system in the body. Ms. Dwoskin will continue to support CMSRI while fulfilling board duties at George Mason University.